Industries > Pharma > mRNA Vaccines and Therapeutics Market Forecast 2019-2029

mRNA Vaccines and Therapeutics Market Forecast 2019-2029

Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, mRNA Therapeutic for Other Diseases, Bioengineered Vaccine, Gene Transcription, Monoclonal Antibody, Gene Therapy, Cell Therapy

PUBLISHED: 07 May 2019
PAGES: 184
PRODUCT CODE: PHA0418

Clear
WOOCS 2.2.1

The mRNA Vaccines and Therapeutics Market is estimated at $3.43 billion in 2018. The Standardized Therapeutic Cancer mRNA Vaccines segment held a share of 35.47% in 2018 and is projected to grow with a CAGR of 9.77% in next ten years.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 184-page report you will receive 130 charts– all unavailable elsewhere.

The 184-page report provides clear detailed insight into the mRNA Vaccines and Therapeutics Market. Discover the key drivers and challenges affecting the market.

Report Scope

• Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market

Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market by type:
• Standardized Therapeutic Cancer mRNA Vaccines
• Individualized Therapeutic Cancer mRNA Vaccines
• Therapeutic Infectious Disease mRNA Vaccines
• mRNA Therapeutic for Other Diseases

Revenue and growth forecasts from 2019 to 2029 for the mRNA Vaccines and Therapeutics market by Mechanism of Action:
• Bioengineered Vaccine
• Gene Therapy (Gene Silencing/Suppression)
• Gene Transcription (Protein Generation)
• Cell Therapy
• Monoclonal Antibody
• Others

Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan and India
• Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa

mRNA Vaccines and Therapeutics Market Forecast 2019-2029

• Discussion and profiles of the leading players in the mRNA Vaccines and Therapeutics market:
• Argos Therapeutics, Inc.
• BioNTech AG
• CureVac AG
• eTheRNA Immunotherapies
• ethris GmbH
• In-Cell-Art
• Moderna Therapeutics
• Sangamo Therapeutics, Inc.
• Tiba Biotech
• Translate Bio, Inc.

• Discussion on mRNA & Delivery Technologies covering Arcelis Technology, Flow Electroporation Technology, Hybrid mRNA Technology, Lipid Nanoparticle (LNP) mRNA Technology, Nanotaxi Technology, RNArt & RNAntibody Technology, UNA & LUNAR Technologies, RNActive Technology, Self-Amplifying mRNA (SAM) Technology, TriMix Technology

• Qualitative analysis of factors that drive and restrain the mRNA Vaccines and Therapeutics market. Trends analysis of the mRNA Vaccines and Therapeutics market.

• mRNA Vaccines and Therapeutics R&D pipeline analysis

• Key Questions Answered by this Report:
• How is the mRNA vaccines and therapeutics market evolving?
• What is driving and restraining the mRNA vaccines and therapeutics market?
• What are the market shares of the leading segments of the mRNA vaccines and therapeutics market in 2018?
• What will be the main driver of the overall market from 2019 to 2029?
• How will the market shares of the leading national markets change by 2029 and which country will lead the market in 2029?
• How will the industry evolve during the period between 2019 and 2029?
• Who are the leading companies in this market?

Visiongain’s study is intended for anyone requiring commercial analyses for the mRNA Vaccines and Therapeutics market. You find data, trends and predictions.

Buy our report today mRNA Vaccines and Therapeutics Market Forecast 2019-2029: Standardized Therapeutic Cancer mRNA Vaccines, Individualized Therapeutic Cancer mRNA Vaccines, Therapeutic Infectious Disease mRNA Vaccines, mRNA Therapeutic for Other Diseases, Bioengineered Vaccine, Gene Transcription, Monoclonal Antibody, Gene Therapy, Cell Therapy.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for mRNA Vaccines and Therapeutics Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for mRNA Vaccines and Therapeutics Market Forecast 2019-2029


Latest Pharma news

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

READ

Categories

Category